Perhaps the most impactful, and commercially lucrative, future application of liquid biopsy lies in its potential for population-scale early cancer detection. Currently, many cancers are not diagnosed until advanced stages, when treatment options are limited and prognosis is poor. Multi-Cancer Early Detection (MCED) tests, which utilize ultra-sensitive liquid biopsy technology to screen...
Italiano 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt